COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA

Clinical trials for COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA trials appear

Sign up with your email to follow new studies for COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test Four-Drug cocktail in fight against tough liver cancer

Disease control Ongoing

This study is comparing two different drug combinations for people with an advanced, mixed-type liver cancer that cannot be removed by surgery. One group gets standard chemotherapy plus an immunotherapy drug. The other group gets those same drugs plus an additional medication des…

Matched conditions: COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 02, 2026 15:25 UTC

COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA

Get alerted when new COMBINED HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA trials appear

Scientists test Four-Drug cocktail in fight against tough liver cancer